Angitia Inc. Ltd.

Bone Health and Osteoporosis

Angitia Inc. Ltd. focuses on postmenopausal osteoporosis and low bone mass, with research centered on improving bone mineral density in women affected by skeletal fragility.

  • Postmenopausal Osteoporosis
  • Low Bone Mass
  • Bone Mineral Density

The sponsor’s clinical activity is directed toward therapies relevant to lumbar spine bone loss and the broader management of age-related weakening of the skeleton.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Denmark Estonia Poland